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Abstract
Objective: To determine the prevalence of metabolic syndrome (MS) and the hypertri-
glyceridemic waist phenotype (HW) in a representative adolescent sample; as well as 
to establish which anthropometric indicator better identifies MS and HW, according to 
gender and adolescent age.
Methods: This cross sectional study had the participation of 800 adolescents (414 girls) 
from 10-19 years old. Anthropometric indicators (body mass index, waist perimeter, 
waist/stature ratio, waist/hip ratio, and central/peripheral skinfolds) were determined 
by standard protocols. For diagnosis of MS, the criteria proposed by de Ferranti et al. 
(2004) were used. HW was defined by the simultaneous presence of increased waist peri-
meter (>75th percentile for age and sex) and high triglycerides (>100 mg/dL). The ability 
of anthropometric indicators was evaluated by Receiver Operating Characteristic curve.
Results: The prevalence of MS was identical to HW (6.4%), without differences between 
genders and the adolescence phases. The waist perimeter showed higher area under the 
curve for the diagnosis of MS, except for boys with 17-19 years old, for whom the waist/sta-
ture ratio exhibited better performance. For diagnosing HW, waist perimeter also showed 
higher area under the curve, except for boys in initial and final phases, in which the waist/
stature ratio obtained larger area under the curve. The central/peripheral skinfolds had 
the lowest area under the curve for the presence of both MS and HW phenotype.
Conclusions: The waist perimeter and the waist/stature showed a better performance to 
identify MS and HW in both genders and in all three phases of adolescence.
© 2015 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
DOI of original article: http://dx.doi.org/10.1016/j.rpped.2014.10.001
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Indicadores antropométricos para identificar síndrome metabólica e fenótipo cintura 
hipertrigliceridêmica: uma comparação entre as três fases da adolescência
Resumo
Objetivo: Determinar a ocorrência de síndrome metabólica (SM) e do fenótipo cintura 
hipertrigliceridêmica (CH) em amostra de adolescentes e estabelecer qual indicador an-
tropométrico melhor identifica SM e CH, de acordo com gênero e fase da adolescência.
Métodos: Estudo transversal com 800 adolescentes (414 meninas) de 10-19 anos. Indicadores 
antropométricos (índice de massa corporal, perímetro da cintura, relação cintura/estatura, 
relação cintura/quadril e relação pregas cutâneas centrais/periféricas) foram determinados 
por protocolos padronizados. Para diagnóstico da SM, foi usada a proposta de Ferranti et al. 
(2004). A CH foi definida pela presença simultânea de perímetro da cintura aumentado (>75 
percentil por idade e sexo) e triglicerídeos elevados (>100 mg/dL). O desempenho dos indi-
cadores antropométricos foi avaliado por meio da curva Receiver Operating Characteristic.
Resultados: A prevalência de SM foi idêntica à de CH (6,4%), sem diferenças entre os 
gêneros e entre as fases da adolescência. O perímetro da cintura apresentou maior área 
abaixo da curva no diagnóstico da SM, exceto para meninos entre 17-19 anos, para os 
quais a relação cintura/estatura exibiu melhor desempenho. No diagnóstico da CH, a 
cintura isolada apresentou maior área abaixo da curva, exceto para os meninos nas fases 
inicial e final da adolescência, nos quais a relação cintura/estatura obteve maior área. 
A relação entre as pregas cutâneas apresentou pior desempenho para identificar SM e CH.
Conclusões: O perímetro da cintura e a relação cintura/estatura mostraram o melhor 
desempenho para identificar SM e CH em ambos os sexos e nas três fases da adolescência.
© 2015 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos os 
direitos reservados.
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Introduction
Chronic, noncommunicable diseases are considered the 
leading cause of mortality in developed and developing 
countries,1 and their incidence rates are rapidly increasing, 
especially in developing countries.2 In Brazil, those diseases 
account for approximately 70% of mortality.3
Metabolic syndrome (MS) is defined as a group of alter-
ations that includes central obesity, dyslipidemia, hypergly-
cemia, insulin resistance, and systemic arterial hyperten-
sion.4 The hypertriglyceridemic waist (HW) phenotype, one 
of the components of MS, is identified by the simultaneous 
presence of high waist circumference and high concentra-
tions of triglycerides.5 Both phenotypes are important pre-
dictors of cardiovascular diseases,2 but the HW is consid-
ered a simpler method for screening individuals at increased 
cardiometabolic risk.6
The prevalence of MS and HW has been widely investigat-
ed in adults,4,5,7-10 but studies in children and adolescents 
are scarce.6,11,12 Studies carried out in Iran with children 
and adolescents aged 6-18 years reported a prevalence of 
14.0% and 8.52% of MS and HW, respectively.6,13 Esmaillzadeh 
et al.11 observed MS prevalence of 10.1% in adolescents 
aged 10-19 years (10.3% in boys and 9.9% for girls) and 6.5% 
of HW (7.3% in boys and 5.6% in girls). Recently, a study 
observed HW prevalence of 7.2% in adolescents aged 
11-17 years in Salvador city, state of Bahia, Brazil.12
Given the paucity of data on the HW phenotype in ado-
lescents and the evidence that the prevalence of MS in 
children has been increasing,2 with a tendency to persist 
into adulthood,14 it becomes necessary to establish what is 
the best body fat distribution indicator for early identifica-
tion of at-risk adolescents, aiming to establish interven-
tions and improve future cardiovascular health.15 Therefore, 
the objective of this study was to determine the preva-
lence of MS and HW phenotype in a representative sample 
of adolescents and to establish which is the best anthropo-
metric indicator to identify MS and the HW phenotype, 
according to gender and stage of adolescence.
Method
This is a cross-sectional study, which is part of a broader 
investigation carried out with adolescents aged 10-19 years, 
of both genders, from the rural and urban population of pub-
lic and private schools (from the 5th year of Elementary 
School to the last year of High School) from the municipality 
of Viçosa, state of Minas Gerais, Brazil. Sample size was cal-
culated using the Epi Info software, release 6.04. Considering 
the population aged 10-19 years and 11 months living in the 
city according to the last census, in a total of 11,898 individ-
uals,16 the expected prevalence is 50%, as the study consid-
ers as outcome multiple cardiovascular risk factors, 5% of 
acceptable variability, 99% confidence level and 20% increase 
to control for potential confounding factors; the sample cal-
culation was estimated at 796 in adolescents. The value of 
50% of prevalence was chosen because, when the informa-
tion is not known, the most conservative method, which also 
maximizes sample size, is to adopt an estimate of 50%.
Inclusion criteria were: no regular use of drugs that 
altered blood glucose, insulinemia, lipid metabolism and/
or blood pressure levels; no participation in weight reduc-
tion and control programs; no regular use of diuretics/lax-
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atives, and not being pregnant or having been previously 
pregnant. Adolescents who met the inclusion criteria and 
were included in the study were separated by gender and 
grouped by age range (10-13 years: initial stage; 14-16 
years: intermediate stage; 17-19 years: final stage).17
Students were selected among those who signed the 
informed consent form, by drawing a random sample, strati-
fied by age group, from each school. When an individual 
refused to participate or withdraw the study, another student 
was selected to replace him/her. All participants and their 
parents/guardians – in the case of adolescents younger than 
18 years – signed the informed consent form, in accordance 
with the Declaration of Helsinki and the rules of Resolution 
number 466/2012 of the National Health Council (CNS). The 
study was approved by the Institutional Review Board of 
Universidade Federal de Viçosa (Of. Ref. number 0140/2010).
Data collection occurred between 7:00 am and 9:30 am 
at the Health Division of Federal University of Viçosa, by 
qualified and previously trained professionals.
Weight and height were measured using standardized 
international techniques, with adolescents barefoot and 
wearing light clothes,18 in an electronic digital scale (LC 
200pp, Marte®, São Paulo, Brazil) and a portable stadiome-
ter (Alturexata®, Belo Horizonte, Brazil). The body mass 
index (BMI) was calculated using the ratio between body 
weight (kg) and the height squared (m2).
Waist circumference was measured at midpoint between 
the lower margin of the lowest rib and the iliac crest, in the 
horizontal plane and at the end of a normal expiration. Hip 
circumference was measured on the gluteal region, over light 
clothes, and comprised the largest horizontal circumference 
between the waist and knees.18 All measurements were per-
formed in duplicate by a single trained evaluator, accepting 
variations of 0.5cm and calculating the mean values, using a 
measuring tape with a length of 2 meters, flexible and inelas-
tic (Cardiomed®, São Luiz, MA, Brazil). Subsequently, the 
waist-to-height (WHtR) and waist-hip (WHR) ratios were cal-
culated by dividing waist circumference (cm) by height (cm) 
and hip circumference (cm), respectively.
Subscapular, suprailiac, triceps and biceps skinfold thickness 
were measured on the right side of the body, and all measure-
ments were taken three times, non-consecutively by a single 
trained evaluator using a Lange Skinfold Caliper (Cambridge 
Scientific, Cambridge, MA, USA), and the mean value was 
used.18 The peripheral skinfold was considered as the sum of 
the triceps and biceps folds, and the central skinfold as the 
sum of the subscapular and suprailiac folds, based on which 
the central/peripheral skinfold ratio was calculated.19
Blood samples were collected from the antecubital vein 
after 12-hour fasting, and serum was separated by centrif-
ugation at 2,2253g for 15 minutes at room temperature 
(2-3 Sigma, Sigma Laborzentrifuzen, OsterodeamHarz, 
Germany). Blood glucose was measured by the glucose oxi-
dase method using the Cobas Mira Plus equipment (Roche 
Diagnostics, GmbH, Montclair, NJ, USA). HDL and triglycer-
ide levels were measured by the automated enzymatic col-
orimetric method in a Cobas Mira Plus equipment (Roche 
Diagnostics GmbH, Montclair, NJ, USA) (Roche Corp.).
Systolic and diastolic blood pressure was measured, after 
a minimum 15-minute rest period, using automatic inflation 
blood pressure monitor (Omron® HEM-741 Model CINT, Kyoto, 
KYT, Japan) and a cuff size that was appropriate for the arm 
perimeter. The measurement was repeated twice in the arm 
with higher pressure value, with a 1-minute interval between 
them, and the mean of the last two measures was used.20
For the diagnosis of MS, the definition proposed by de 
Ferranti et al. was used,14 which is based on the presence of 
three of the following criteria: waist circumference >75th 
percentile for age and gender of the assessed population; 
HDL <50 mg/dL (except for boys aged 15-19, for whom a 
value <45 mg/dL was considered); triglycerides ≥100 mg/dL; 
systolic and/or diastolic blood pressure >90th percentile for 
gender, age and height, and fasting glucose ≥100 mg/dL. It 
should be noted that the criterion of de Ferranti et al. pro-
poses glycemia ≥110, but we chose to use the latest recom-
mendations of the American Diabetes Association.21
The HW phenotype was defined according to the cutoffs 
used to define MS. The simultaneous presence of increased 
waist circumference (≥75th percentile for age and gender of 
the study population) and high levels of serum triglycerides 
(≥100 mg/dL) was considered HW.22
The database was created, and data were entered twice 
(double entry) using Microsoft Office Excel 2007, and the 
statistical analyses were performed using SPSS for Windows, 
release 17.0, and MedCalc, release 9.3. The Kolmogorov-
Smirnov test, graphical methods and asymmetry coefficient 
(skewness >1; asymmetric) were used to evaluate the vari-
ables for normality. Anthropometric, clinical and metabolic 
variables were compared between stages by ANOVA, fol-
lowed by Tukey post hoc or Kruskal-Wallis test, followed by 
Mann-Whitney with Bonferroni correction for variables with 
parametric and nonparametric distribution, respectively. For 
comparisons between genders, Student’s t test or Mann-
Whitney test was used for variables with parametric and 
non-parametric distribution, respectively. The occurrence of 
MS and HW, as well as their individual components, was com-
pared between stages and between genders using Pearson’s 
chi-square test. Additionally, receiver operator characteris-
tic (ROC) curves were prepared, and the area under the 
curve was calculated in order to identify the best anthropo-
metric indicator associated with MS and HW phenotype.
Results
All adolescents that attended public and private schools, both 
in urban and rural areas of the municipality of Viçosa/MG, 
were contacted in 2010. In the same year, the municipality 
had a total of 27 schools and all of them participated in the 
study. All adolescents who agreed to participate and gave 
their free and informed consent were included in this study – a 
total of 828 adolescents. Of those, 28 were excluded for the 
following reasons: use of anticonvulsant medication (1); histo-
ry of hypothyroidism (1); inadequate fasting (2); technical 
impossibility of collecting blood samples (1); use of antide-
pressants (fluoxetine) (9); history of myelomeningocele (1); 
presence of nasal cancer (1); growth hormone use (1); hor-
monal alterations (3); use of supplements and/or vitamins (5); 
previous pregnancy (2); swollen foot, with plaster (1). Thus, 
the studied adolescents consisted of 414 girls and 383 boys, 
with a mean age of 14.72 years (SD=2.95). Anthropometric, 
clinical and metabolic characteristics are shown in Table 1.
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Table 1 Characteristics of the adolescents according to gender and stage of adolescence.
Stage of adolescence Total
Initial Intermediary Final
Girls
N 157 134 123 414
Age (years) 11.57 (1.07)a 15.67 (0.94)b 18.17 (0.65)c 14.86 (2.90)f
BMI (kg/m2) 18.80 (3.37)a 21.59 (3.99) 21.19 (3.32)c 20.41 (3.78)f
WC (cm) 68.82 (9.66)a 76.22 (9.15) 75.48 (9.10)c 73.20 (9.92)f
HC (cm) 79.67 (9.17)a 93.01 (9.02) 92.88 (8.01)c 87.91 (10.89)f
WHR 0.86 (0.05)a 0.82 (0.05) 0.81 (0.05)c 0.83 (0.06)f
WHtR 0.46 (0.06) 0.47 (0.06) 0.47 (0.06) 0.47 (0.06)
CPR 1.61 (0.59)a 1.78 (0.44) 1.86 (0.48)c 1.74 (0.52)f
Glycemia (mg/dL) 86.08 (6.55)a 82.49 (6.79) 81.74 (5.93)c 83.63 (6.73)f
HDL (mg/dL) 52.56 (12.31) 51.35 (11.75) 51.86 (11.73) 51.96 (11.94)
TG (mg/dL) 78.70 (37.24) 71.38 (35.57) 67.54 (31.27)c 73.01 (35.25)f
SBP (mmHg) 95.59 (9.93)a 99.61 (7.57) 100.86 (8.30)c 98.46 (9.02)f
DBP (mmHg) 60.61 (7.42) 61.79 (6.75) 63.48 (6.79)c 61.85 (7.10)f
Boys
N 179 95 112 386
Age (years) 11.71 (1.13)a 15.56 (0.89)b 18.29 (0.83)c 14.57 (3.01)f
BMI (kg/m2) 18.34 (3.73)a 20.88 (3.32)b 22.25 (3.85)c 20.10 (4.04)f
WC (cm) 67.10 (10.61)a 74.47 (9.27) 77.79 (9.96)c 72.02 (11.14)f
HC (cm) 75.72 (9.73)a 89.40 (8.71)b 92.77 (9.22)c 84.04 (12.18)f
WHR 0.88 (0.04)a 0.83 (0.05) 0.84 (0.04)c 0.86 (0.05)f
WHtR 0.45 (0.06) 0.44 (0.05) 0.45 (0.05) 0.45 (0.06)
CPR 1.34 (0.47)a 1.67 (0.49)b 1.94 (0.54)c 1.59 (0.56)f
Glycemia (mg/dL) 86.74 (6.56) 86.68 (6.23)b 83.74 (6.73)c 85.86 (6.65)f
HDL (mg/dL) 51.31 (13.72)a 46.77 (11.01) 46.42 (10.48)c 48.77 (12.41)f
TG (mg/dL) 69.54 (33.53) 66.56 (38.55) 66.88 (31.30) 68.03 (34.16)
SBP (mmHg) 96.17 (10.33)a 103.98 (10.50)b 110.21 (8.56)c 102.17 (11.57)f
DBP (mmHg) 58.18 (6.85) 58.66 (7.92) 59.75 (8.08) 58.76 (7.50)
Total
N 336 229 235 800
Age (years) 11.64 (1.10)a 15.63 (0.92)b 18.22 (0.74)c,e 14.72 (2.95)e,f
BMI (kg/m2) 18.55 (3.57)a 21.30 (3.74) 21.69 (3.61)c 20.26 (3.91)f
WC (cm) 67.91 (10.20)a 75.50 (9.22) 76.58 (9.56)c 72.63 (10.53)f
HC (cm) 77.57 (9.66)a 91.52 (9.05) 92.83 (8.59)c 86.04 (11.68)e,f
WHR 0.87 (0.05)a,e 0.82 (0.05) 0.82 (0.05)c 0.84 (0.05)e,f
WHtR 0.45 (0.06) 0.46 (0.06) 0.46 (0.06) 0.46 (0.06)e
CPR 1.46 (0.54)a,e 1.74 (0.46)b 1.90 (0.51)c 1.67 (0.56)e,f
Glycemia (mg/dL) 86.43 (6.55)a 84.23 (6.87)b 82.69 (6.39)c,d 84.70 (6.77)e,f
HDL (mg/dL) 51.90 (13.08) 49.45 (11.65) 49.27 (11.46)c 50.42 (12.26)e,f
TG (mg/dL) 73.82 (35.55) 69.38 (36.83) 67.23 (31.21) 70.61 (34.79)
SBP (mmHg) 95.90 (10.13)a 101.42 (9.14)b,e 105.32 (9.63)c 100.25 (10.48)e,f
DBP (mmHg) 59.32 (7.21) 60.49 (7.40) 61.70 (7.65)c 60.35 (7.45)e,f
Data shown as mean (standard deviation).
BMI, body mass index; WC, waist circumference; HC, hip circumference; WHR, waist-hip ratio; WHtR, waist-height ratio; CPR, central/
peripheral skinfold ratio; HDL, high-density lipoprotein; TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic blood pressure.
a Differences between the initial and intermediary stages.
b Differences between intermediary and final stages.
c Differences between initial and final stages.
d p<0.05 between genders.
e p<0.01 between genders.
f p<0.01 between stages.
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Table 2 Prevalence of metabolic syndrome, hypertriglyceridemic waist and individual components according to gender and 
stage of adolescence.
Stage Waist ≥P75 Elevated TG Low HDL Elevated 
glycemia 
Elevated BP MS HW
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Girls
Initial (n=157) 38 (24.2) 35 (22.3) 70 (44.6) 3 (1.9) 4 (2.5) 15 (9.5) 11 (7.0)
Intermediary (n=134) 34 (25.4) 22 (16.4) 64 (47.8) 0 (0) 2 (1.5) 7 (5.2) 9 (6.7)
Final (n=123) 31 (25.2) 16 (13.0) 50 (40.7) 0 (0) 1 (0.8) 5 (4.1) 6 (4.9)
Total (n=414) 103 (24.9) 73 (17.6)a 184 (44.4) 3 (0.7) 7 (1.7)a 27 (6.5) 26 (6.3)
Boys
Initial (n=179) 134 (25.1) 22 (12.3) 88 (49.2) 1 (0.6) 6 (3.4) 14 (7.8) 12 (6.7)
Intermediary (n=95) 24 (25.3) 10 (10.5) 45 (47.4) 1 (1.0) 6 (6.3) 4 (4.2) 5 (5.3)
Final (n=112) 29 (25.9) 13 (11.6) 49 (43.8) 1 (0.9) 4 (3.6) 6 (5.4) 8 (7.1)
Total (n=386) 98 (25.4) 45 (11.7)a 182 (47.2) 3 (0.8) 16 (4.2)a 24 (6.2) 25 (6.5)
Total
Initial (n=336) 83 (24.7) 57 (16.9) 158 (47.0) 4 (1.2) 10 (2.9) 29 (8.6) 23 (6.9)
Intermediary (n=229) 58 (25.3) 32 (13.9) 109 (47.6) 1 (0.4) 8 (3.5) 11 (4.8) 14 (6.1)
Final (n=235) 60 (25.5) 29 (12.3) 99 (42.1) 1 (0.4) 5 (2.1) 11 (4.7) 14 (5.9)
Total (n=800) 201 (25.1) 118 (14.8) 366 (45.8) 6 (0.8) 23 (2.9) 51 (6.4) 51 (6.4)
MS, metabolic syndrome; HW, hypertriglyceridemic waist; P, percentile; TG, triglycerides; HDL, high-density lipoprotein; BP, blood 
pressure.
a p<0.01 between genders.
Girls had higher hip circumference values, waist/height 
ratio, central/peripheral skinfold ratio, HDL, and diastolic 
blood pressure when compared to boys. Boys had higher 
blood glucose and systolic blood pressure levels. The 
parameters body mass index, waist circumference, tri-
glycerides and age did not differ between the genders. 
Some variables did not change with age, namely the waist/
height ratio and HDL in girls and waist/height ratio, tri-
glycerides and diastolic blood pressure in boys. When com-
paring the stages of adolescence, it was observed that, in 
females, the intermediate and final stages did not differ 
between each other (early stage<intermediate stage=final 
stage), whereas in boys, the parameters usually differed 
between the stages (initial stage<intermediate stage<final 
stage, except for glucose levels, which decreased from the 
intermediate to the final stage).
Table 2 discloses the presence of MS, HW phenotype and 
their components, according to the gender and adoles-
cence stage. The prevalence of MS was identical to that of 
HW (6.4%), with no differences between genders and 
between the stages of adolescence. Among the MS compo-
nents, the most prevalent was low HDL. Regarding pheno-
type, the prevalence of abdominal obesity was higher than 
that of hypertriglyceridemia. The prevalence of high blood 
pressure was higher in boys (p<0.01), while hypertriglycer-
idemia was more prevalent in girls (p<0.01).
When assessing which anthropometric indicator showed 
better performance in the prediction of MS and HW, waist 
circumference showed the highest absolute values of area 
under the curve in all analyses, except for boys in the ini-
tial and final stages in the diagnosis of HW and for boys in 
the final stage in the diagnosis of MS, in whom the waist-
to-height ratio showed higher absolute value of area under 
the curve. In turn, the central/peripheral skinfold ratio 
showed the smallest areas under the curve for the presence 
of both MS and HW (Table 3). The areas under the curves 
were calculated using the receiver operating characteristic 
(ROC) curves (Figs. 1 and 2).
Discussion
The present study, carried out with adolescents in a represen-
tative sample of rural and urban, public and private school 
populations from Viçosa, Minas Gerais, Brazil, identified a 
prevalence rate of 6.4% for MS and HW phenotype, with no 
differences between genders and adolescence  stages.
MS is a health problem in the pediatric group in devel-
oped countries and especially in developing ones2; howev-
er, as yet there is no formal, unified criterion for its diag-
nosis in children and adolescents, and the use of different 
criteria for this definition has been observed in different 
populations, making it difficult to compare prevalence.13 
The prevalence of MS in the United States, according to the 
same criteria used in this study, was estimated at 12.9% in 
Mexican-Americans, 10.9% among non-Hispanic whites, and 
2.5% for non-Hispanic blacks.14 Kelishadi et al.13 observed a 
prevalence of 14% (13% for girls and 14% for boys) of MS 
using similar criteria to those of the present study. In Brazil, 
a study of children and adolescents in Salvador, state of 
Bahia, observed the prevalence of 6.6% (8.5% in girls and 
4.7% in boys).23
The prevalence of HW phenotype in this study (6.4%) was 
similar to that observed in a study with adolescents aged 
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10-19 years in Tehran (Iran) (6.4%),11 and similar to that 
identified in children and adolescents aged 6-18 years from 
Iran (8.5%),6 in adolescents aged 10-19 years from the UK 
(7.3%),22 and in adolescents aged 11-17 years from Salvador/
Bahia, Brazil (7.2%).12 However, a study carried out in 
England24 with obese children and adolescents aged 8-18 
years found a prevalence of 40% of HW phenotype.22 
Differences in MS and HW phenotype prevalence can be 
attributed to variations in the cutoffs used to classify cen-
tral obesity, hypertriglyceridemia, and other components 
of MS between different studies and their differences 
regarding nutritional status, sexual maturation, race/eth-
nicity and life habits between regions.12,25
Among the components of MS, low HDL concentrations 
were the most prevalent, which can be explained by the 
current nutritional transition process experienced in Brazil, 
where food consumption consists mainly of high-energy 
food and, among adolescents, one can observe a high fre-
quency of consumption of cookies, sausages, hotdogs, bolo-
gna, sandwiches and salty snacks. The prevalence of inad-
equate intake of saturated fat was greater than 80%, and 
the consumption of cream-filled cookies, which contain 
hydrogenated fats and trans-fatty acids, was four times 
higher in this group compared to adults.26 Low levels of 
physical activity commonly observed in this age group con-
stitute another factor that possibly contributes to the high 
prevalence of low HDL levels.27
In this sense, although the experience of using the HW 
phenotype as a diagnostic tool for cardiometabolic risk in 
adolescents is still limited, it has been documented that in 
adults, this phenotype is capable of identifying individuals 
with the atherogenic triad, comprising increased concen-
trations of small and dense LDL, apolipoprotein B and 
hyperinsulinemia, and who are at high risk for cardiovascu-
lar disease.5 In a longitudinal study with adults in Tehran 
(n=6,834) the HW phenotype increased the risk of cardio-
vascular disease incidence.9 The results of the present 
study suggest that these two measures, WC and tri-
glycerides, can be used to substitute higher-cost indicators 
to identify adolescents at risk of metabolic disorders.
The second objective of this study was to determine 
which anthropometric index performs best to identify the 
occurrence of MS and HW phenotype. The ROC analyses 
demonstrated that WC and waist/height ratio had a high-
er area under the curve to identify both MS and HW. 
Studies have shown that the WC in adolescents is a good 
Table 3 Areas under the curve (95%CI) of anthropometric indicators as predictors of metabolic syndrome and 
hypertriglyceridemic waist phenotype.
Gender Stage BMI WC WHR WHtR CPR
MS
Girls Initial 0.906  
(0.849; 0.946)b
0.906  
(0.849; 0.946)b
0.789  
(0.717; 0.850)b
0.881  
(0.819; 0.927)b
0.767  
(0.693; 0.831)b
Intermediary 0.778 
(0.699; 0.846)a
0.835 (0.761; 
0.894)b
0.706 (0.622; 
0.782)
0.818 (0.742; 
0.879)b
0.733  
(0.650; 0.806)a
Final 0.763 
(0.678; 0.835)a
0.902  
(0.835; 0.948)b
0.961  
(0.910; 0.987)b
0.864  
(0.790; 0.919)b
0.595  
(0.503; 0.682)
Boys Initial 0.914  
(0.863; 0.951)b
0.929  
(0.881; 0.962)b
0.861  
(0.802; 0.908)b
0.924  
(0.875; 0.958)b
0.839  
(0.777; 0.890)b
Intermediary 0.945  
(0.878; 0.981)b
0.964  
(0.904; 0.991)b
0.902  
(0.824; 0.954)b
0.953 
(0.889; 0.986)b
0.967  
(0.908; 0.992)b
Final 0.910  
(0.841; 0.956)b
0.948  
(0.889; 0.981)b
0.931  
(0.867; 0.970)b
0.976  
(0.928; 0.995)b
0.700  
(0.607; 0.783)
HW
Girls Initial 0.926  
(0.874; 0.962)a
0.959  
(0.915; 0.984)a
0.944  
(0.896; 0.975)a
0.954  
(0.909; 0.981)a
0.815  
(0.746; 0.873)a
Intermediary 0.872  
(0.815; 0.929)
0.917  
(0.870; 0.965)
0.955  
(0.920; 0.990)
0.970  
(0.941; 0.999)
0.902  
(0.852; 0.953)
Final 0.994  
(0.960; 0.998)b
1.000  
(0.970; 1.000)b
0.917  
(0.853; 0.959)b
0.999  
(0.967; 1.000)a
0.575  
(0.483; 0.664)
Boys Initial 0.927  
(0.878; 0.960)b
0.943  
(0.898; 0.972)b
0.894  
(0.839; 0.935)b
0.953  
(0.911; 0.979)b
0.797  
(0.730; 0.853)b
Intermediary 0.967  
(0.908; 0.992)b
0.978  
(0.924; 0.997)b
0.984  
(0.933; 0.998)b
0.977  
(0.922; 0.996)b
0.885  
(0.803; 0.941)b
Final 0.965  
(0.912; 0.990)b
0.961  
(0.906; 0.988)b
0.867  
(0.790; 0.924)b
0.977  
(0.929; 0.996)a
0.512  
(0.415; 0.607)
CI, confidence interval; MS, metabolic syndrome; HW, hypertriglyceridemic waist; BMI, body mass index (kg/m2); WC, waist 
circumference (cm); WHR, waist/hip ratio; WHtR, waist/height ratio; CPR, central/peripheral skinfold ratio.
a p<0.05.
b p<0.01.
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Figure 1 Receiver operator characteristic (ROC) curves for metabolic syndrome according to gender and stage of adolescence. 
BMI, body mass index (kg/m2); WC, waist circumference (cm); WHR, waist/hip ratio; WHtR, waist/height ratio; CPR, central/
peripheral skinfold ratio.
indicator of visceral abdominal fat content28 and cardio-
vascular risk factors,13,29,30 and it can be a simple tool to 
identify MS in children and adolescents.13,23,25 In a study 
carried out in children and adolescents (8-18 years), 
waist/height ratio showed to be a slightly better predic-
tor of MS (area under the curve=0.83 [0.78 to 0.89]) than 
WC (area under the curve=0.79 [0.73 to 0.85]) and BMI 
(area under the curve=0.79 [0.72 to 0.85]).23 One of the 
advantages of waist/height ratio is the possibility of using 
the cutoff ≥0.5, which is applicable to both genders and 
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all ages, to identify children and adolescents at cardio-
vascular risk.15 Body mass index, an indicator widely used 
in pediatric clinical practice for the assessment of nutri-
tional status, showed a worse performance than waist cir-
cumference and waist/height ratio, which is consistent 
ROC: Girls (10-13.9 years) ROC: Boys (10-13.9 years)
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Figure 2 Receiver operator characteristic (ROC) curves for hypertriglyceridemic waist phenotype according to gender and 
stage of adolescence. BMI, body mass index (kg/m2); WC, waist circumference (cm); WHR, waist/hip ratio; WHtR, waist/height 
ratio; CPR, central/peripheral skinfold ratio.
with previous studies that demonstrated the superiority 
of waist circumference as an isolated measure or adjust-
ed by height.13,25,28 Additionally, waist circumference is 
less affected than body mass index by gender, ethnicity, 
and total fat.28
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The index with the worst performance was the central/
peripheral skinfold ratio, which can be explained by the 
fact that skinfolds estimate subcutaneous and not visceral 
fat, and the latter is the one associated with increased 
risk.31 Moreover, the validity of indicators that are based on 
the association between two or more measures, compared 
to individual measures, to predict cardiovascular risk has 
been questioned.32
This study has some limitations, such as the cross-sec-
tional design, which does not allow the assessment of the 
precise effects of growth on waist measurement, and eth-
nicity, which is one of the factors that affect body fat dis-
tribution. However, the effects of the latter were not 
assessed, as the classification could be inaccurate due to 
the great multi-ethnicity of the Brazilian population. 
Another limitation was the impossibility to assess the stage 
of sexual maturation of the participants. Despite of puber-
ty effects on body fat distribution, we attempted to control 
them by employing specific WC cutoffs for age and gender. 
Finally, lifestyle characteristics (food and physical activity 
habits) could affect the association between the occur-
rence of obesity and other associated metabolic disorders; 
therefore they should be included in further studies.
It can be concluded that, according to the study results, 
HW phenotype is a simple tool to substitute MS in screening 
individuals at cardiometabolic risk. Regarding the capacity 
of the anthropometric indicators, waist circumference and 
waist/height ratio showed better performance to identify 
MS and HW, two major phenotypes of cardiometabolic risk 
in both genders and at all stages of adolescence, which 
emphasizes the importance of incorporating the measure-
ment of these parameters in pediatric clinical routine.
These observations lead to the demand for a national 
waist circumference reference curve for adolescents, 
which could be used both in the clinical setting and in pop-
ulation surveillance to identify young, but at high risk, 
asymptomatic individuals who might benefit from an early 
intervention. It is believed that such iniciatives could 
impact on primary prevention in public health.
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